A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Sebastian, Martin; Schroeder, Andreas; Scheel, Birgit; Hon, Henoch S.; Muth, Anke; von Boehmer, Lotta; Zippelius, Alfred; Mayer, Frank; Reck, Martin; Atanackovic, Djordje; Thomas, Michael; Schneller, Folker; Stoehlmacher, Jan; Bernhard, Helga; Groeschel, Andreas; Lander, Thomas; Probst, Jochen; Strack, Tanja; Wiegand, Volker; Gnad-Vogt, Ulrike; Kallen, Karl-Josef; Hoerr, Ingmar; von der Muelbe, Florian; Fotin-Mleczek, Mariola; Knuths, Alexander; Koch, Sven D.

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer

Autor(en):

Sebastian, Martin; Schroeder, Andreas; Scheel, Birgit; Hon, Henoch S.; Muth, Anke; von Boehmer, Lotta; Zippelius, Alfred; Mayer, Frank; Reck, Martin; Atanackovic, Djordje; Thomas, Michael; Schneller, Folker; Stoehlmacher, Jan; Bernhard, Helga; Groeschel, Andreas; Lander, Thomas; Probst, Jochen; Strack, Tanja; Wiegand, Volker; Gnad-Vogt, Ulrike; Kallen, Karl-Josef; Hoerr, Ingmar; von der Muelbe, Florian; Fotin-Mleczek, Mariola; Knuths, Alexander; Koch, Sven D.

Tübinger Autor(en):

Mayer, Frank

Erschienen in:

Cancer Immunology Immunotherapy (2019), Bd. 68, H. 5, S. 799-812

Verlagsangabe:

Springer

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1007/s00262-019-02315-x

ISSN:

1432-0851